BioMarin Pharmaceutical Inc. Posted August 6, 2025

Senior Manager/Associate Director, International Regulatory Affairs

Tokyo, Japan Fulltime-Regular
Regulatory Affairs Associate Director
Notify me about similar jobs

BioMarin Pharmaceutical Inc. is the source of truth for this posting and owns the application process. We surface normalized context and market comparison you won't find on the original listing.

About this opportunity

<div><p style="margin: 0.0pt;text-align: center;"><img src="data:image/jpeg;base64,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" width="305" height="46" alt="" /></p><p style="margin: 0.0pt;text-align: center;"><span style="font-family: Arial;font-size: 10.0pt;"> </span></p><p style="margin: 0.0pt;text-align: center;"><span style="font-family: Arial;font-size: 10.0pt;"> </span></p><p style="margin: 0.0pt;text-align: center;"><span style="font-family: Arial;font-size: 10.0pt;"> </span></p><h1 style="margin: 0.0pt;text-align: center;"><span style="font-family: Arial;font-size: 14.0pt;font-weight: bold;">JOB DESCRIPTION</span></h1><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;"> </span></p><div style="text-align: center;"><table cellspacing="0" cellpadding="0" style="border-collapse: collapse;margin: 0 auto;width: 445.6pt;"><tbody><tr><td style="background-color: rgb(224,224,224);padding-left: 4.9pt;padding-right: 5.03pt;vertical-align: top;width: 165.6pt;border-width: 1.0pt 0.75pt 0.75pt 1.0pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;font-weight: bold;">Job Title:</span><span style="font-family: Arial;font-size: 12.0pt;"> </span></p></td><td style="padding-left: 5.03pt;padding-right: 4.9pt;vertical-align: top;width: 257.4pt;border-width: 1.0pt 1.0pt 0.75pt 0.75pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;">Senior Manager</span><span style="font-family: Arial;font-size: 12.0pt;">,</span><span style="font-family: Arial;font-size: 12.0pt;"> International Regulatory Affairs</span></p></td></tr><tr><td style="background-color: rgb(224,224,224);padding-left: 4.9pt;padding-right: 5.03pt;vertical-align: top;width: 165.6pt;border-width: 0.75pt 0.75pt 0.75pt 1.0pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;font-weight: bold;">Department / </span><span style="font-family: Arial;font-size: 12.0pt;font-weight: bold;">Cost</span><span style="font-family: Arial;font-size: 12.0pt;font-weight: bold;"> </span><span style="font-family: Arial;font-size: 12.0pt;font-weight: bold;">Center</span><span style="font-family: Arial;font-size: 12.0pt;font-weight: bold;">: </span></p></td><td style="padding-left: 5.03pt;padding-right: 4.9pt;vertical-align: top;width: 257.4pt;border-width: 0.75pt 1.0pt 0.75pt 0.75pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;">Regulatory – 2</span><span style="font-family: Arial;font-size: 12.0pt;">10</span></p></td></tr><tr><td style="background-color: rgb(224,224,224);padding-left: 4.9pt;padding-right: 5.03pt;vertical-align: top;width: 165.6pt;border-width: 0.75pt 0.75pt 0.75pt 1.0pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;font-weight: bold;">Reports to (Job Title):</span><span style="font-family: Arial;font-size: 12.0pt;"> </span></p></td><td style="padding-left: 5.03pt;padding-right: 4.9pt;vertical-align: top;width: 257.4pt;border-width: 0.75pt 1.0pt 0.75pt 0.75pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;">Head of </span><span style="font-family: Arial;font-size: 12.0pt;">APAC </span><span style="font-family: Arial;font-size: 12.0pt;">Regulatory Affairs</span></p></td></tr><tr><td style="background-color: rgb(224,224,224);padding-left: 4.9pt;padding-right: 5.03pt;vertical-align: top;width: 165.6pt;border-width: 0.75pt 0.75pt 0.75pt 1.0pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;font-weight: bold;">Job Code:</span></p></td><td style="padding-left: 5.03pt;padding-right: 4.9pt;vertical-align: top;width: 257.4pt;border-width: 0.75pt 1.0pt 0.75pt 0.75pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;"> </span></p></td></tr><tr><td style="background-color: rgb(224,224,224);padding-left: 4.9pt;padding-right: 5.03pt;vertical-align: top;width: 165.6pt;border-width: 0.75pt 0.75pt 0.75pt 1.0pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;font-weight: bold;">Location:</span><span style="font-family: Arial;font-size: 12.0pt;"> </span></p></td><td style="padding-left: 5.03pt;padding-right: 4.9pt;vertical-align: top;width: 257.4pt;border-width: 0.75pt 1.0pt 0.75pt 0.75pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;">Tokyo</span></p></td></tr><tr><td style="background-color: rgb(224,224,224);padding-left: 4.9pt;padding-right: 5.03pt;vertical-align: top;width: 165.6pt;border-width: 0.75pt 0.75pt 1.0pt 1.0pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;font-weight: bold;">Date Prepared:</span><span style="font-family: Arial;font-size: 12.0pt;"> </span></p></td><td style="padding-left: 5.03pt;padding-right: 4.9pt;vertical-align: top;width: 257.4pt;border-width: 0.75pt 1.0pt 1.0pt 0.75pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;">February</span><span style="font-family: Arial;font-size: 12.0pt;"> 202</span><span style="font-family: Arial;font-size: 12.0pt;">5</span></p></td></tr></tbody></table></div><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;font-weight: bold;"> </span></p><div style="text-align: center;"><table cellspacing="0" cellpadding="0" style="border-collapse: collapse;margin: 0 auto;width: 442.9pt;"><tbody><tr style="height: 32.8pt;"><td style="background-color: rgb(224,224,224);padding-left: 4.9pt;padding-right: 4.65pt;vertical-align: top;width: 138.6pt;border-width: 1.0pt 1.5pt 1.0pt 1.0pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;text-align: center;"><span style="font-family: Arial;font-size: 10.0pt;font-weight: bold;"> </span></p><p style="margin: 0.0pt;text-align: center;"><span style="font-family: Arial;font-size: 10.0pt;font-weight: bold;"> Full-Time     </span><span style="font-family: Arial;font-size: 10.0pt;font-weight: bold;"> Part-Time</span></p><p style="margin: 0.0pt;text-align: center;"><span style="font-family: Arial;font-size: 10.0pt;font-weight: bold;"> </span></p></td><td style="background-color: rgb(224,224,224);padding-left: 4.65pt;padding-right: 4.65pt;vertical-align: top;width: 133.2pt;border-width: 1.0pt 1.5pt 1.0pt 1.5pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;text-align: center;"><span style="font-family: Arial;font-size: 10.0pt;font-weight: bold;"> </span></p><p style="margin: 0.0pt;text-align: center;"><span style="font-family: Arial;font-size: 10.0pt;font-weight: bold;"> Regular     </span><span style="font-family: Arial;font-size: 10.0pt;font-weight: bold;"> Temporary</span></p><p style="margin: 0.0pt;text-align: center;"><span style="font-family: Arial;font-size: 10.0pt;font-weight: bold;"> </span></p></td><td style="background-color: rgb(224,224,224);padding-left: 4.65pt;padding-right: 4.9pt;vertical-align: top;width: 137.7pt;border-width: 1.0pt 1.0pt 1.0pt 1.5pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;text-align: center;"><span style="font-family: Arial;font-size: 10.0pt;font-weight: bold;"> </span></p><p style="margin: 0.0pt;text-align: center;"><span style="font-family: Arial;font-size: 10.0pt;font-weight: bold;"> Exempt     </span><span style="font-family: Arial;font-size: 10.0pt;font-weight: bold;"> Non-Exempt</span></p><p style="margin: 0.0pt;text-align: center;"><span style="font-family: Arial;font-size: 10.0pt;font-weight: bold;"> </span></p></td></tr></tbody></table></div><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;font-weight: bold;"> </span></p><table cellspacing="0" cellpadding="0" style="border-collapse: collapse;margin-left: 0.0pt;"><tbody><tr><td style="padding-left: 4.9pt;padding-right: 4.9pt;vertical-align: top;width: 432.0pt;border: 1.0pt solid rgb(0,0,0);"><div style="clear: both;margin: 0.0pt;border: 0.75pt solid rgb(0,0,0);"><h2 style="background-color: rgb(224,224,224);font-weight: normal;margin: 0.0pt;padding-left: 4.0pt;padding-right: 4.0pt;padding-top: 1.0pt;"><span style="font-family: Arial;font-size: 12.0pt;font-weight: bold;text-decoration: underline;">SUMMARY DESCRIPTION</span></h2><p style="background-color: rgb(224,224,224);margin: 0.0pt;padding-bottom: 1.0pt;padding-left: 4.0pt;padding-right: 4.0pt;"></p></div><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;">We are seeking a highly motivated, energetic professional capable of working effectively in fast-paced environment to join our International Regulatory Affairs team. This position will be responsible for </span><span style="font-family: Arial;font-size: 12.0pt;">developing </span><span style="font-family: Arial;font-size: 12.0pt;">the strategy, preparation and execution o</span><span style="font-family: Arial;font-size: 12.0pt;">f regulatory submissions (marketing applications (MAs) and post-marketing maintenance) for </span><span style="font-family: Arial;font-size: 12.0pt;">BioMarin </span><span style="font-family: Arial;font-size: 12.0pt;">products, interfacing with the Japanese regulatory authorities (</span><span style="font-family: Arial;font-size: 12.0pt;">e.g</span><span style="font-family: Arial;font-size: 12.0pt;">.</span><span style="font-family: Arial;font-size: 12.0pt;"> </span><span style="font-family: Arial;font-size: 12.0pt;">MHLW</span><span style="font-family: Arial;font-size: 12.0pt;">, </span><span style="font-family: Arial;font-size: 12.0pt;">PMDA), and for providing insight and support for clinical development in Japan. </span><span style="font-family: Arial;font-size: 12.0pt;">This</span><span style="font-family: Arial;font-size: 12.0pt;"> </span><span style="font-family: Arial;font-size: 12.0pt;">position</span><span style="font-family: Arial;font-size: 12.0pt;"> is</span><span style="font-family: Arial;font-size: 12.0pt;"> </span><span style="font-family: Arial;font-size: 12.0pt;">based in the Tokyo office</span><span style="font-family: Arial;font-size: 12.0pt;">.</span></p></td></tr></tbody></table><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;font-weight: bold;"> </span></p><table cellspacing="0" cellpadding="0" style="border-collapse: collapse;margin-left: 0.0pt;"><tbody><tr><td style="background-color: rgb(224,224,224);padding-left: 4.9pt;padding-right: 4.9pt;vertical-align: top;width: 432.0pt;border-width: 1.0pt 1.0pt 0.75pt 1.0pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;"><span style="background-color: rgb(224,224,224);font-family: Arial;font-size: 12.0pt;font-weight: bold;text-decoration: underline;">RESPONSIBILITIES</span></p><p style="margin: 0.0pt;"></p></td></tr><tr><td style="padding-left: 4.9pt;padding-right: 4.9pt;vertical-align: top;width: 432.0pt;border-width: 0.75pt 1.0pt 1.0pt 1.0pt;border-color: rgb(0,0,0);border-style: solid;"><div style="border-top-color: rgb(228,237,243);border-top-width: 0.75pt;clear: both;margin: 0.0pt;"><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;">Develop Japanese Regulatory filing strategies and identify risks and potential gating factors. </span><span style="font-family: Arial;font-size: 12.0pt;">Play an active role in </span><span style="font-family: Arial;font-size: 12.0pt;">leading </span><span style="font-family: Arial;font-size: 12.0pt;">the </span><span style="font-family: Arial;font-size: 12.0pt;">strategic </span><span style="font-family: Arial;font-size: 12.0pt;">planning </span><span style="font-family: Arial;font-size: 12.0pt;">and preparation of complex submissions including but not limited to the following: JNDA</span><span style="font-family: Arial;font-size: 12.0pt;">/J</span><span style="font-family: Arial;font-size: 12.0pt;">s</span><span style="font-family: Arial;font-size: 12.0pt;">NDA</span><span style="font-family: Arial;font-size: 12.0pt;"> (content development, assembly of the dossier, submission through approval); post-marketing maintenance including </span><span style="font-family: Arial;font-size: 12.0pt;">re-examinations, </span><span style="font-family: Arial;font-size: 12.0pt;">JAN applications, </span><span style="font-family: Arial;font-size: 12.0pt;">expedited pathway applications </span><span style="font-family: Arial;font-size: 12.0pt;">and any other required submissions in Japan. Must ensure all submissions are prepared in accordance with J</span><span style="font-family: Arial;font-size: 12.0pt;">apanese </span><span style="font-family: Arial;font-size: 12.0pt;">regulations. </span><span style="font-family: Arial;font-size: 12.0pt;">Serve as primary liaison with the </span><span style="font-family: Arial;font-size: 12.0pt;">r</span><span style="font-family: Arial;font-size: 12.0pt;">egulatory authorities (e.g., MHLW</span><span style="font-family: Arial;font-size: 12.0pt;">, </span><span style="font-family: Arial;font-size: 12.0pt;">PMDA) and interface on behalf of BioMarin</span><span style="font-family: Arial;font-size: 12.0pt;"> to negotiate as needed to support plans for new drug registrations and activities for existing product licenses. Lead in preparation for and execution of </span><span style="font-family: Arial;font-size: 12.0pt;">a</span><span style="font-family: Arial;font-size: 12.0pt;">gency meetings.</span><br /><span style="font-family: Arial;font-size: 12.0pt;">Actively participate in multi-functional global team environment, and </span><span style="font-family: Arial;font-size: 12.0pt;">i</span><span style="font-family: Arial;font-size: 12.0pt;">nterface closely with U.S. and other global BioMarin offices to align on operational and strategic deliverables.</span></p><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;">Evaluate </span><span style="font-family: Arial;font-size: 12.0pt;">new and emerging </span><span style="font-family: Arial;font-size: 12.0pt;">regulations/guidance to advise BioMarin on the Japanese Regulatory environment and changes that could impact BioMarin’s products o</span><span style="font-family: Arial;font-size: 12.0pt;">r plans. </span></p></div></td></tr></tbody></table><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;font-weight: bold;"> </span></p><table cellspacing="0" cellpadding="0" style="border-collapse: collapse;margin-left: 0.0pt;"><tbody><tr><td style="background-color: rgb(224,224,224);padding-left: 4.9pt;padding-right: 4.9pt;vertical-align: top;width: 432.0pt;border-width: 1.0pt 1.0pt 0.75pt 1.0pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;"><span style="background-color: rgb(224,224,224);font-family: Arial;font-size: 12.0pt;font-weight: bold;text-decoration: underline;">EDUCATION</span></p><p style="margin: 0.0pt;"></p></td></tr><tr><td style="padding-left: 4.9pt;padding-right: 4.9pt;vertical-align: top;width: 432.0pt;border-width: 0.75pt 1.0pt 1.0pt 1.0pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;">A bachelor of science degree in</span><span style="font-family: Arial;font-size: 12.0pt;"> </span><span style="font-family: Arial;font-size: 12.0pt;">life science</span><span style="font-family: Arial;font-size: 12.0pt;">.</span></p><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;">Qualified Pharmacist</span><span style="font-family: Arial;font-size: 12.0pt;"> </span><span style="font-family: Arial;font-size: 12.0pt;">is </span><span style="font-family: Arial;font-size: 12.0pt;">a plus</span><span style="font-family: Arial;font-size: 12.0pt;">.</span><span style="font-family: Arial;font-size: 11.0pt;">  </span></p><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;">Fluent in Japanese and English.</span></p></td></tr></tbody></table><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;font-weight: bold;"> </span></p><table cellspacing="0" cellpadding="0" style="border-collapse: collapse;margin-left: 0.0pt;"><tbody><tr><td style="background-color: rgb(224,224,224);padding-left: 4.9pt;padding-right: 4.9pt;vertical-align: top;width: 432.0pt;border-width: 1.0pt 1.0pt 0.75pt 1.0pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;"><span style="background-color: rgb(224,224,224);font-family: Arial;font-size: 12.0pt;font-weight: bold;text-decoration: underline;">EXPERIENCE</span></p><p style="margin: 0.0pt;"></p></td></tr><tr><td style="padding-left: 4.9pt;padding-right: 4.9pt;vertical-align: top;width: 432.0pt;border-width: 0.75pt 1.0pt 1.0pt 1.0pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;">Mi</span><span style="font-family: Arial;font-size: 12.0pt;">nimum of </span><span style="font-family: Arial;font-size: 12.0pt;">ten years of industry experience with at least </span><span style="font-family: Arial;font-size: 12.0pt;">si</span><span style="font-family: Arial;font-size: 12.0pt;">x</span><span style="font-family: Arial;font-size: 12.0pt;"> </span><span style="font-family: Arial;font-size: 12.0pt;">years of</span><span style="font-family: Arial;font-size: 12.0pt;"> </span><span style="font-family: Arial;font-size: 12.0pt;">experience in Regulatory Affairs </span><span style="font-family: Arial;font-size: 12.0pt;">in the biotechnology or pharmaceutical industries, including </span><span style="font-family: Arial;font-size: 12.0pt;">good</span><span style="font-family: Arial;font-size: 12.0pt;"> </span><span style="font-family: Arial;font-size: 12.0pt;">knowledge and understanding of the </span><span style="font-family: Arial;font-size: 12.0pt;">Japanese</span><span style="font-family: Arial;font-size: 12.0pt;"> regulatory environment.  </span></p><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;">Proven track record for preparing, submitting, and gaining approvals for JNDAs. </span></p><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;">The candidate is expected to have a thorough understanding of relevant drug development</span><span style="font-family: Arial;font-size: 12.0pt;"> </span><span style="font-family: Arial;font-size: 12.0pt;">regulations and guidelines and to have outstanding interpersonal and communication (written and verbal) skills and effective task planning and coordination abilities. </span></p><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;">Experience as clinical scientist </span><span style="font-family: Arial;font-size: 12.0pt;">and/</span><span style="font-family: Arial;font-size: 12.0pt;">or in-depth understanding of clinical </span><span style="font-family: Arial;font-size: 12.0pt;">development</span><span style="font-family: Arial;font-size: 12.0pt;"> as a regulatory st</span><span style="font-family: Arial;font-size: 12.0pt;">rategist is </span><span style="font-family: Arial;font-size: 12.0pt;">highly </span><span style="font-family: Arial;font-size: 12.0pt;">desired.</span></p><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;">Proficiency with computer and standard software programs is required. </span><span style="font-family: Arial;font-size: 12.0pt;">The c</span><span style="font-family: Arial;font-size: 12.0pt;">andidate </span><span style="font-family: Arial;font-size: 12.0pt;">is expected t</span><span style="font-family: Arial;font-size: 12.0pt;">o </span><span style="font-family: Arial;font-size: 12.0pt;">be flu</span><span style="font-family: Arial;font-size: 12.0pt;">ent in English, both verbal and written (technical). </span><span style="font-family: Arial;font-size: 12.0pt;"> Strong collaborative skills are needed as this position requires close working relationships with stakeholders both inside and outside of the compa</span><span style="font-family: Arial;font-size: 12.0pt;">ny.  </span><span style="font-family: Arial;font-size: 12.0pt;">Good</span><span style="font-family: Arial;font-size: 12.0pt;"> </span><span style="font-family: Arial;font-size: 12.0pt;">verbal, written and presentation skills are also required.  </span></p></td></tr></tbody></table><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;font-weight: bold;"> </span></p><table cellspacing="0" cellpadding="0" style="border-collapse: collapse;margin-left: 0.0pt;width: 94.1083%;height: 168.344px;"><tbody><tr style="height: 67.1719px;"><td style="background-color: rgb(224,224,224);padding-left: 4.9pt;padding-right: 4.9pt;vertical-align: top;width: 0.0%;border-width: 1.0pt 1.0pt 0.75pt;border-color: rgb(0,0,0);border-style: solid;height: 67.1719px;"><p style="margin: 0.0pt;"><span style="background-color: rgb(224,224,224);font-family: Arial;font-size: 12.0pt;font-weight: bold;text-decoration: underline;">CONTACTS</span></p><p style="margin: 0.0pt;"></p></td></tr><tr style="height: 101.172px;"><td style="padding-left: 4.9pt;padding-right: 4.9pt;vertical-align: top;width: 0.0%;border-width: 0.75pt 1.0pt 1.0pt;border-color: rgb(0,0,0);border-style: solid;height: 101.172px;"><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;">The candidate must interact with </span><span style="font-family: Arial;font-size: 12.0pt;">Japan</span><span style="font-family: Arial;font-size: 12.0pt;"> </span><span style="font-family: Arial;font-size: 12.0pt;">team members, </span><span style="font-family: Arial;font-size: 12.0pt;">International team members, and colleagues based in the global company headquarters. </span></p><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;">BioMarin is Headquartered in California.</span></p><p style="line-height: 12.0pt;margin: 0.0pt 0.0pt 14.25pt;"><span style="font-family: Arial;font-size: 12.0pt;">The position will report directly to the </span><span style="font-family: Arial;font-size: 12.0pt;">Head of APAC</span><span style="font-family: Arial;font-size: 12.0pt;"> Regulatory Affairs based in </span><span style="font-family: Arial;font-size: 12.0pt;">Tokyo.</span></p></td></tr></tbody></table><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;font-weight: bold;"> </span></p><table cellspacing="0" cellpadding="0" style="border-collapse: collapse;margin-left: 0.0pt;"><tbody><tr><td style="background-color: rgb(224,224,224);padding-left: 4.9pt;padding-right: 4.9pt;vertical-align: top;width: 432.0pt;border-width: 1.0pt 1.0pt 0.75pt 1.0pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;"><span style="background-color: rgb(224,224,224);font-family: Arial;font-size: 12.0pt;font-weight: bold;text-decoration: underline;">SUPERVISOR RESPONSIBILITY</span></p><p style="margin: 0.0pt;"></p></td></tr><tr><td style="padding-left: 4.9pt;padding-right: 4.9pt;vertical-align: top;width: 432.0pt;border-width: 0.75pt 1.0pt 1.0pt 1.0pt;border-color: rgb(0,0,0);border-style: solid;"><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 11.0pt;">No direct reports.</span></p></td></tr></tbody></table><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;font-weight: bold;"> </span></p><p style="margin: 0.0pt;"><span style="font-family: Arial;font-size: 12.0pt;font-weight: bold;"> </span></p></div>

Job details

Seniority
Associate Director
Function
Regulatory Affairs
Therapeutic area
Not listed
Location
Tokyo, Japan
Employment type
Fulltime-Regular

How this role compares

Computed from every other active Regulatory Affairs role in our database, not just this employer's listings.

We currently track 215 comparable Associate Director Regulatory Affairs roles across 72 biopharma companies.

215Comparable roles tracked
212Currently active
72Companies hiring similar roles
30Countries represented

Salary context

63 of 215 peers report a salary range (USD, annualized)

Peers share this role's job function and a matching or adjacent seniority level -- not necessarily the same therapeutic area or country.

This roleSubject Not listed on this posting
Peer group range $115,000 – $245,000 (median $176,800)

Where these roles are based

Top locations among the 215 comparable roles

United States80
India22
Japan17
Poland16
China11
United Kingdom10

+ 24 more countries

Seniority mix

215 of 215 peers have a known seniority level

Manager131
Senior44
Associate Director40

Therapeutic area mix

14 of 215 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden

Oncology8
Immunology4
Dermatology & Aesthetics2

Similar opportunities

The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.

60%similar
Johnson & Johnson Chiyoda, Japan Associate Director
Same function Same seniority Same country
50%similar
Regeneron Japan KK Tokyo, Japan Manager
Same function Adjacent seniority Same country
50%similar
Regeneron Japan KK Tokyo, Japan Manager
Same function Adjacent seniority Same country
50%similar
BMS Japan Otemachi-JP, Japan Manager
Same function Adjacent seniority Same country
50%similar
BMS Japan Otemachi-JP, Japan Manager
Same function Adjacent seniority Same country
50%similar
Amgen K.K. Tokyo, Japan Manager
Same function Adjacent seniority Same country

Notify me about similar jobs

Get an email when we spot other openings like this one – same job function, comparable seniority, roles you'd actually want to see.

How we calculate "similar"

No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.

Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.

60%
[Innovative Medicine] R&D, Associate Director/Manager, Global Regulatory Policy & Intelligence, Japan Regulatory Policy, Regulatory Affairs
Johnson & Johnson · Chiyoda, Japan · Associate Director
Function Therapeutic area Seniority Country
50%
Senior Manager, Labeling & Regulatory Affairs
BMS Japan · Otemachi-JP, Japan · Manager
Function Therapeutic area Adjacent seniority Country
50%
Position Japan Regulatory Strategy Manager
Amgen K.K. · Tokyo, Japan · Manager
Function Therapeutic area Adjacent seniority Country
50%
Associate Manager, CMC Regulatory Affairs
Regeneron Japan KK · Tokyo, Japan · Manager
Function Therapeutic area Adjacent seniority Country
Unmatched or unknown dimensions score exactly the same: 0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.